ACCOUNTS - Final Accounts preparation

Registered number: 15958158

LEADERS IN LIVER HEALTH LIMITED

UNAUDITED

FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 30 SEPTEMBER 2025

LEADERS IN LIVER HEALTH LIMITED

REGISTERED NUMBER: 15958158

BALANCE SHEET

AS AT 30 SEPTEMBER 2025

		2025
Note		£

Fixed assets
Tangible assets	4		27,580

Creditors: amounts falling due within one year	5	(39,323)
Net current (liabilities)/assets			(39,323)
Total assets less current liabilities			(11,743)

Net (liabilities)/assets			(11,743)

Capital and reserves
Called up share capital	6	100
Profit and loss account		(11,843)
		(11,743)

The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the period in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 20 August 2026.

Dr Patrick Kennedy

Director

The notes on pages 2 to 3 form part of these financial statements.

Page 1

LEADERS IN LIVER HEALTH LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 30 SEPTEMBER 2025

1.	General information

Leaders in Liver Health Limited ("the Company") is a private company limited by shares, incorporated in
England and Wales. The registered office is Leytonstone House, 3 Hanbury Drive, Leytonstone, London,
E11 1GA. The Company's principal activity was medical consultancy.

These are the first set of accounts for the Company, covering the period from incorporation on 16 September 2024, to 30 September 2025.

2.Accounting policies

2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the requirements and the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

2.2

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Plant and machinery

20%

straight-line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

2.3

Creditors

Short-term creditors are measured at the transaction price.

Employees

The average monthly number of employees, including the director, during the period was 1.

Page 2

LEADERS IN LIVER HEALTH LIMITED

NOTES TO THE FINANCIAL STATEMENTS

FOR THE PERIOD ENDED 30 SEPTEMBER 2025

4.	Tangible fixed assets

		Plant and machinery
		£
	Cost or valuation
	Additions	31,223
	At 30 September 2025	31,223
	Depreciation
	Charge for the period on owned assets	3,643
	At 30 September 2025	3,643
	Net book value
	At 30 September 2025	27,580

5.	Creditors: Amounts falling due within one year
		2025
		£

	Amounts owed to group undertakings	39,323

6.	Share capital
		2025
		£

		Allotted, called up and fully paid

		100 Ordinary shares of £1.00 each	100

On incorporation, 100 £1 Ordinary shares were issued at par.

7.	Controlling party

The ultimate parent is KennedyAMP Consultancy Limited which owns 100% of the share capital in Leaders In Liver Health limited.

Page 3